Assistant Professor of Urology and Oncology
Director, Division of Testis Cancer
Director of Social Media
Brady Urological Institute; Sidney Kimmel Comprehensive Cancer
Dr. Phillip Pierorazio, originally from New York, received his undergraduate degree from Georgetown University in Washington, DC and his medical degree from Columbia University, College of Physicians & Surgeons in New York City. Prior to starting residency, he was accepted and spent a year as a Doris Duke Clinical Research Fellow in Urologic Oncology. After completing residency and advanced training at the Johns Hopkins Hospital, he joined the staff of the James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Urology and Oncology.
Dr. Pierorazio has expertise in all malignancies of the urinary tract, including kidney, bladder, prostate, testis, adrenal, penile and urethral cancer. He performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder, prostate and retroperitoneal lymph node dissection for testicular cancer. He has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced urological cancers.
He is the Director of the Division of Testicular Cancer and works with a number of testicular cancer advocacy groups around the country. He runs the testicular cancer "Go-Team" and coordinates the departments research efforts in testicular cancer.
Paralleling his clinical interests, his research interests and publications include high-risk urologic malignancies including prostate and bladder cancer. He has a special interest in testicular (see above) and kidney cancer (renal cell carcinoma), studying both advanced and early-stage disease. He runs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry one of the largest studies of its kind â following patients with small, localized kidney tumors (cT1a, â¤4cm) who choose active surveillance or immediate surgery. The National Comprehensive Cancer Network (NCCN) recently awarded Dr. Pierorazio a Young Investigatorâs Award for his work with the DISSRM Registry.
Dr. Pierorazio is the recipient of a number of academic awards including the American Urologic Association Essay Contest and has presented his research at a number of national and international meetings. He has written and published numerous research articles, textbook chapters, and video presentations in the field Urologic Oncology.